Status:
RECRUITING
Adenosine vs Diltiazem for Treatment of SVT in the ED
Lead Sponsor:
Anne E. Zepeski
Conditions:
Supraventricular Tachycardia (SVT)
Eligibility:
All Genders
18-100 years
Phase:
PHASE4
Brief Summary
This is a small, pilot study with a primary goal of assessing patient perceptions of two medication treatments for supraventricular tachycardia in adult patients treated in the Emergency Department.
Eligibility Criteria
Inclusion
- Adult patients (18 years and older)
- Diagnosis of acute, stable SVT in the emergency department
Exclusion
- Receipt of IV AV-nodal blocking agents prior to study enrollment (includes adenosine, non-dihydropyridine calcium channel blockers, beta-antagonists in pre-hospital and/or hospital setting).
- Reported or confirmed personal history of Wolff-Parkinson-White (WPW) syndrome
- History of heart failure with reduce ejection fraction (HFrEF) (LVEF\</= 40%)
- Severe bronchoconstrictive lung disease
- Prior hypersensitivity to study medication
- Previously enrolled in pilot study
- Pregnant
- Incarcerated
Key Trial Info
Start Date :
August 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06993038
Start Date
August 1 2025
End Date
December 1 2026
Last Update
September 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa Health Care
Iowa City, Iowa, United States, 52242